TY - JOUR
T1 - Treatment of acute and chronic heart failure.
AU - Talbert, Robert L.
PY - 2003
Y1 - 2003
N2 - Heart failure is a common, costly, and generally fatal condition that most often results from coronary artery disease or hypertension. All patients with heart failure need education about the importance of sodium restriction and daily weight monitoring. Most patients with heart failure require combination therapy that includes a diuretic, an ACE inhibitor, a beta-blocker, and digoxin. Selected patients may benefit from alternative or additional medications, such as anticoagulants in individuals with atrial fibrillation or ARBs in those who cannot tolerate ACE inhibitor therapy. Investigational medications and devices for heart failure are under active study.
AB - Heart failure is a common, costly, and generally fatal condition that most often results from coronary artery disease or hypertension. All patients with heart failure need education about the importance of sodium restriction and daily weight monitoring. Most patients with heart failure require combination therapy that includes a diuretic, an ACE inhibitor, a beta-blocker, and digoxin. Selected patients may benefit from alternative or additional medications, such as anticoagulants in individuals with atrial fibrillation or ARBs in those who cannot tolerate ACE inhibitor therapy. Investigational medications and devices for heart failure are under active study.
UR - http://www.scopus.com/inward/record.url?scp=17144449016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17144449016&partnerID=8YFLogxK
U2 - 10.1331/154434503322612320
DO - 10.1331/154434503322612320
M3 - Article
C2 - 14626517
AN - SCOPUS:17144449016
VL - 43
SP - S18-19
JO - Journal of the American Pharmaceutical Association. American Pharmaceutical Association
JF - Journal of the American Pharmaceutical Association. American Pharmaceutical Association
SN - 1544-3191
IS - 5 Suppl 1
ER -